AU2608201A - Compounds for immunotherapy and diagnosis of colon cancer and methods for their use - Google Patents

Compounds for immunotherapy and diagnosis of colon cancer and methods for their use

Info

Publication number
AU2608201A
AU2608201A AU26082/01A AU2608201A AU2608201A AU 2608201 A AU2608201 A AU 2608201A AU 26082/01 A AU26082/01 A AU 26082/01A AU 2608201 A AU2608201 A AU 2608201A AU 2608201 A AU2608201 A AU 2608201A
Authority
AU
Australia
Prior art keywords
immunotherapy
diagnosis
compounds
methods
colon cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26082/01A
Inventor
Darin R. Benson
Yuqiu Jiang
Gordon E. King
Michael J. Lodes
Madeleine Joy Meagher
Heather Secrist
John A. Stolk
Tongtong Wang
Jiangchun Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2608201A publication Critical patent/AU2608201A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU26082/01A 1999-12-30 2000-12-29 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use Abandoned AU2608201A (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US47629699A 1999-12-30 1999-12-30
US09476296 1999-12-30
US48032100A 2000-01-10 2000-01-10
US09480321 2000-01-10
US50462900A 2000-02-15 2000-02-15
US09504629 2000-02-15
US51944400A 2000-03-06 2000-03-06
US09519444 2000-03-06
US57525100A 2000-05-19 2000-05-19
US09575251 2000-05-19
US60944800A 2000-06-29 2000-06-29
US09609448 2000-06-29
US64981100A 2000-08-28 2000-08-28
US09649811 2000-08-28
PCT/US2000/035596 WO2001049716A2 (en) 1999-12-30 2000-12-29 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use

Publications (1)

Publication Number Publication Date
AU2608201A true AU2608201A (en) 2001-07-16

Family

ID=27569804

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26082/01A Abandoned AU2608201A (en) 1999-12-30 2000-12-29 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use

Country Status (4)

Country Link
EP (1) EP1242598A2 (en)
AU (1) AU2608201A (en)
CA (1) CA2396036A1 (en)
WO (1) WO2001049716A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784548B2 (en) * 2001-03-16 2006-04-27 Ortho-Clinical Diagnostics, Inc. Reg-like protein

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6962779B1 (en) 1998-10-02 2005-11-08 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
US6893818B1 (en) 1999-10-28 2005-05-17 Agensys, Inc. Gene upregulated in cancers of the prostate
EP1285071A2 (en) * 2000-05-15 2003-02-26 Emory University Novel dual oxidases as mitogenic and endocrine regulators
JP2004512023A (en) * 2000-06-09 2004-04-22 コリクサ　コーポレイション Compositions and methods for treatment and diagnosis of colon cancer
US6635750B1 (en) 2000-07-20 2003-10-21 Millennium Pharmaceuticals, Inc. B7-H2 nucleic acids, members of the B7 family
AU2001285568A1 (en) * 2000-07-28 2002-03-22 Michael Andrew Mcguckin Mucin
AU2001294999A1 (en) * 2000-08-07 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20030219768A1 (en) * 2001-11-02 2003-11-27 Beebe Jean S. Lung cancer therapeutics and diagnostics
GB0130720D0 (en) * 2001-12-21 2002-02-06 Serono Internat S A Proteins
DE10230631A1 (en) * 2002-07-02 2004-01-22 Metagen Pharmaceuticals Gmbh Uses of Ngal-binding substances for the diagnosis and treatment of cancer
TWI340168B (en) * 2003-05-07 2011-04-11 Tosoh Corp Method of detecting micrometastasis
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
WO2008026008A1 (en) * 2006-08-29 2008-03-06 Oxford Genome Sciences (Uk) Ltd Protein
US8535677B2 (en) 2006-06-06 2013-09-17 Oxford Biotherapeutics, Ltd. Antibody drug conjugate treatment of colorectal cancer
CA2759538C (en) 2009-04-20 2018-07-24 Oxford Biotherapeutics Ltd Antibodies specific to cadherin-17

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5041289A (en) * 1987-11-13 1991-08-20 Becton Dickinson And Company Method of purging residual tumor cells in vitro with lymphokine activated cytotoxic cells
WO1999001020A2 (en) * 1997-07-01 1999-01-14 Human Genome Sciences, Inc. 19 human secreted proteins
AU7499198A (en) * 1997-05-21 1998-12-11 Johns Hopkins University, The Gene expression profiles in normal and cancer cells
US5929033A (en) * 1998-02-10 1999-07-27 Incyte Pharmaceuticals, Inc. Extracellular mucous matrix glycoprotein
US6183968B1 (en) * 1998-03-27 2001-02-06 Incyte Pharmaceuticals, Inc. Composition for the detection of genes encoding receptors and proteins associated with cell proliferation
EP1080227B1 (en) * 1998-05-21 2006-02-08 Diadexus, Inc. Method of diagnosing, monitoring, and staging colon cancer
IL139686A0 (en) * 1998-06-02 2002-02-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2000037643A2 (en) * 1998-12-23 2000-06-29 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
WO2000021991A1 (en) * 1998-10-15 2000-04-20 Genetics Institute, Inc. SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
EP1185648B1 (en) * 1999-06-02 2007-03-21 Genentech, Inc. Methods and compositions for inhibiting neoplastic cell growth
CA2390093A1 (en) * 1999-12-10 2001-06-14 Incyte Genomics, Inc. Extracellular matrix and cell adhesion molecules

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU784548B2 (en) * 2001-03-16 2006-04-27 Ortho-Clinical Diagnostics, Inc. Reg-like protein

Also Published As

Publication number Publication date
WO2001049716A2 (en) 2001-07-12
EP1242598A2 (en) 2002-09-25
WO2001049716A3 (en) 2002-01-31
CA2396036A1 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
AU2387900A (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2010699A (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU4185100A (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
AU1807401A (en) Compositions and methods for therapy and diagnosis of breast cancer
AU1656501A (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2608201A (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU7484800A (en) Imaging of scattering media using relative detector values
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
PL350890A1 (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
AU6425800A (en) Agents for the diagnosis, prognosis and treatment of malignant diseases
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU7817500A (en) Method of tumor imaging
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2003218208A1 (en) Methods for diagnosis and prognosis of cancer
AU2001266790A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU3326000A (en) Means of early examination of malignant tumor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase